517 related articles for article (PubMed ID: 26818660)
21. Comparison of outcomes of cyclosporine A and infliximab for steroid-refractory acute severe ulcerative colitis.
Song EM; Oh EH; Hwang SW; Park SH; Yang DH; Byeon JS; Myung SJ; Yang SK; Ye BD
J Gastroenterol Hepatol; 2021 Sep; 36(9):2463-2470. PubMed ID: 33783045
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the therapeutic efficacy and safety between tacrolimus and infliximab for moderate-to-severe ulcerative colitis: a single center experience.
Nuki Y; Esaki M; Asano K; Maehata Y; Umeno J; Moriyama T; Nakamura S; Matsumoto T; Kitazono T
Scand J Gastroenterol; 2016; 51(6):700-5. PubMed ID: 26818468
[TBL] [Abstract][Full Text] [Related]
23. Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab.
Laharie D; Bourreille A; Branche J; Allez M; Bouhnik Y; Filippi J; Zerbib F; Savoye G; Vuitton L; Moreau J; Amiot A; Cosnes J; Ricart E; Dewit O; Lopez-Sanroman A; Fumery M; Carbonnel F; Bommelaer G; Coffin B; Roblin X; van Assche G; Esteve M; Farkkila M; Gisbert JP; Marteau P; Nahon S; de Vos M; Lambert J; Mary JY; Louis E;
Gut; 2018 Feb; 67(2):237-243. PubMed ID: 28053054
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of infliximab, cyclosporine and tacrolimus on ulcerative colitis: A meta-analysis.
Jia X; Guo R; Hu Z; Liu J; Liu J; Li B; Yang Q; He J
Medicine (Baltimore); 2020 Oct; 99(44):e22894. PubMed ID: 33126341
[TBL] [Abstract][Full Text] [Related]
25. Extent of Early Clinical Response to Infliximab Predicts Long-term Treatment Success in Active Ulcerative Colitis.
Murthy SK; Greenberg GR; Croitoru K; Nguyen GC; Silverberg MS; Steinhart AH
Inflamm Bowel Dis; 2015 Sep; 21(9):2090-6. PubMed ID: 26099066
[TBL] [Abstract][Full Text] [Related]
26. Clinical efficacy of infliximab in moderate to severe ulcerative colitis in a latin american referral population.
Juliao F; Marquez J; Aristizabal N; Yepes C; Zuleta J; Gisbert JP
Digestion; 2013; 88(4):222-8. PubMed ID: 24281150
[TBL] [Abstract][Full Text] [Related]
27. Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: early and late outcome and predictors of colectomy.
Monterubbianesi R; Aratari A; Armuzzi A; Daperno M; Biancone L; Cappello M; Annese V; Riegler G; Orlando A; Viscido A; Meucci G; Gasbarrini A; Guidi L; Lavagna A; Sostegni R; Onali S; Papi C; Kohn A;
J Crohns Colitis; 2014 Aug; 8(8):852-8. PubMed ID: 24472490
[TBL] [Abstract][Full Text] [Related]
28. Comparison of Safety and Efficacy of Tacrolimus versus Infliximab for Active Ulcerative Colitis.
Takeuchi K; Shimoyama T; Yamamoto T
Dig Dis; 2018; 36(2):106-112. PubMed ID: 29050007
[TBL] [Abstract][Full Text] [Related]
29. Similar Clinical and Surgical Outcomes Achieved with Early Compared to Late Anti-TNF Induction in Mild-to-Moderate Ulcerative Colitis: A Retrospective Cohort Study.
Ma C; Beilman CL; Huang VW; Fedorak DK; Wong K; Kroeker KI; Dieleman LA; Halloran BP; Fedorak RN
Can J Gastroenterol Hepatol; 2016; 2016():2079582. PubMed ID: 27478817
[TBL] [Abstract][Full Text] [Related]
30. Clinical outcome of adalimumab therapy in patients with ulcerative colitis previously treated with infliximab: a Danish single-center cohort study.
Christensen KR; Steenholdt C; Brynskov J
Scand J Gastroenterol; 2015 Aug; 50(8):1018-24. PubMed ID: 25861832
[TBL] [Abstract][Full Text] [Related]
31. Infliximab or cyclosporine for acute severe ulcerative colitis: a retrospective analysis.
Dean KE; Hikaka J; Huakau JT; Walmsley RS
J Gastroenterol Hepatol; 2012 Mar; 27(3):487-92. PubMed ID: 22098019
[TBL] [Abstract][Full Text] [Related]
32. Cyclosporine A for induction of remission in severe ulcerative colitis.
Shibolet O; Regushevskaya E; Brezis M; Soares-Weiser K
Cochrane Database Syst Rev; 2005 Jan; (1):CD004277. PubMed ID: 15674937
[TBL] [Abstract][Full Text] [Related]
33. Managing paediatric acute severe ulcerative colitis according to the 2011 ECCO-ESPGHAN guidelines: Efficacy of infliximab as a rescue therapy.
Aloi M; D'Arcangelo G; Capponi M; Nuti F; Vassallo F; Civitelli F; Oliva S; Pagliaro G; Cucchiara S
Dig Liver Dis; 2015 Jun; 47(6):455-9. PubMed ID: 25733340
[TBL] [Abstract][Full Text] [Related]
34. Infliximab in steroid-dependent ulcerative colitis: effectiveness and predictors of clinical and endoscopic remission.
Armuzzi A; Pugliese D; Danese S; Rizzo G; Felice C; Marzo M; Andrisani G; Fiorino G; Sociale O; Papa A; De Vitis I; Rapaccini GL; Guidi L
Inflamm Bowel Dis; 2013 Apr; 19(5):1065-72. PubMed ID: 23448790
[TBL] [Abstract][Full Text] [Related]
35. Outcomes of salvage therapy for steroid-refractory acute severe ulcerative colitis: ciclosporin vs. infliximab.
Croft A; Walsh A; Doecke J; Cooley R; Howlett M; Radford-Smith G
Aliment Pharmacol Ther; 2013 Aug; 38(3):294-302. PubMed ID: 23786158
[TBL] [Abstract][Full Text] [Related]
36. Infliximab as rescue therapy in hospitalised patients with steroid-refractory acute ulcerative colitis: a long-term follow-up of 211 Swedish patients.
Sjöberg M; Magnuson A; Björk J; Benoni C; Almer S; Friis-Liby I; Hertervig E; Olsson M; Karlén P; Eriksson A; Midhagen G; Carlson M; Lapidus A; Halfvarson J; Tysk C;
Aliment Pharmacol Ther; 2013 Aug; 38(4):377-87. PubMed ID: 23799948
[TBL] [Abstract][Full Text] [Related]
37. Long-term outcome in patients with ulcerative colitis treated with intravenous cyclosporine A is determined by previous exposure to thiopurines.
Walch A; Meshkat M; Vogelsang H; Novacek G; Dejaco C; Angelberger S; Mikulits A; Miehsler W; Gangl A; Reinisch W
J Crohns Colitis; 2010 Oct; 4(4):398-404. PubMed ID: 21122535
[TBL] [Abstract][Full Text] [Related]
38. Short-Term and Long-Term Outcomes of Infliximab and Tacrolimus Treatment for Moderate to Severe Ulcerative Colitis: Retrospective Observational Study.
Otsuka T; Ooi M; Tobimatsu K; Wakahara C; Watanabe D; Adachi S; Yasutomi E; Yamairi H; Ku Y; Yoshida M; Hoshi N; Kodama Y
Kobe J Med Sci; 2018 Dec; 64(4):E140-E148. PubMed ID: 30728340
[TBL] [Abstract][Full Text] [Related]
39. Frequency, predictors, and consequences of maintenance infliximab therapy intensification in ulcerative colitis.
Fernández-Salazar L; Barrio J; Muñoz F; Muñoz C; Pajares R; Rivero M; Prieto V; Legido J; Bouhmidi A; Herranz M; González-Redondo G; Fernández N; Santos F; Sánchez-Ocaña R; Joao D;
Rev Esp Enferm Dig; 2015 Sep; 107(9):527-33. PubMed ID: 26334458
[TBL] [Abstract][Full Text] [Related]
40. Improved outcome of acute severe ulcerative colitis while using early predictors of corticosteroid failure and rescue therapies.
Llaó J; Naves JE; Ruiz-Cerulla A; Gordillo J; Mañosa M; Maisterra S; Cabré E; Garcia-Planella E; Guardiola J; Domènech E
Dig Liver Dis; 2016 Jun; 48(6):608-12. PubMed ID: 27012443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
